Corporate News Report
Forum Markets (FRMM) Trading activity as of 06:48 PM Central Europe, Wednesday 21 Oct 2026
- Price movement (24 h) – Forum Markets shares fell −2.11 % during the 24‑hour period ending at 06:48 PM Central Europe.
- Current price – The stock trades at USD 3.48 on major exchanges.
- Shares outstanding – Total supply is 13.2 million shares.
- Market capitalisation – The market value of all outstanding shares equals USD 43.8 million.
- Volume (last 24 h) – Approximately USD 591.8 k of Forum Markets shares were traded.
- Month‑end performance – Since the end of the previous month, the share price has declined −33.94 %.
- Technical indicators – The simple moving average over the last 200 trading days is USD 4.57.
- 52‑week range – The all‑time high of the last 52 weeks was USD 24.44 (28 Oct 2025). The 52‑week low was USD 1.76 (13 Apr 2026).
Recent Performance of Peer Companies
| Ticker | 24‑h change | Current price (USD) | Market capitalisation (USD mn) | Key corporate event |
|---|---|---|---|---|
| THRY (Thryv) | +4.39 % | 1.15 | 50.7 | Third‑quarter 2026 financial results to be released 5 Nov, followed by a conference call. |
| TZOO (Travelzoo) | +3.21 % | 5.22 | 50.9 | No material corporate action reported. |
| BOLD (Boundless Bio) | +5.19 % | 2.44 | 52.5 | Beneficial ownership changes involving Kevin Tang‑affiliated entities; acquisitions of several hundred thousand shares at $2.30‑$2.40 per share. |
| RNXT (Renovorx) | +3.45 % | 1.24 | 52.4 | No material corporate action reported. |
| GOSS (Gossamer Bio) | +13.64 % | 10.3 | 51.6 | No material corporate action reported. |
Company Profile – Forum Markets
Forum Markets, formerly listed as 180 Life Sciences Corp., is a biotechnology firm focused on developing novel therapeutics for inflammatory conditions. The company is headquartered in the United States and trades on the Nasdaq stock exchange under the ticker FRMM. It went public on 2 June 2017. The company’s global customer base includes pharmaceutical and biotechnology partners; more information is available on its website at www.180lifesciences.com .
